United Kingdom· GB-APID-43792511000001100
Leqembi 200mg/2ml concentrate for solution for infusion vials
A lecanemab product containing lecanemab, registered in United Kingdom by Eisai Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Lecanemab is registered in 10 of 19 countries.
Countries holding a registration under ATC N06DX04 (lecanemab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Lecanemab · ATC N06DX04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Lecanemab
- Manufacturer
- Eisai Ltd
- Country
- United Kingdom (GB)
- ATC code
- N06DX04
- ATC class
- Lecanemab
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5036519004722
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lecanemab in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesLECANEMAB AUTOINJECTOREisai Inc.
- CzechiaLEQEMBIEisai GmbH, Frankfurt am Main
- BelgiumLeqembi 100 mg/mlEisai
- Japanレカネマブ（遺伝子組換え）エーザイ
- IrelandLEQEMBI 100 mg/mL concentrate for solution for infusionEisai GmbH
- IcelandLeqembiEisai GmbH
- SpainLEQEMBI 100 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONEisai Gmbh
- NetherlandsLEQEMBI 100 mg/ml concentraat voor oplossing voor infusieEisai GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Leqembi
- Liechtenstein · Leqembi
- Norway · Leqembi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/26057d9e-e418-4ac2-9285-60bc16ab9355 GET /v1/drugs/26057d9e-e418-4ac2-9285-60bc16ab9355?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "43792511000001100",
"desc": "Leqembi 200mg/2ml concentrate for solution for infusion vials (Eisai Ltd)",
"form": "Solution for infusion",
"vpid": "43793011000001104",
"source": "dmd",
"vtm_id": "43842211000001107",
"strength": "100 mg",
"substance": "Lecanemab",
"ingredient": "Lecanemab",
"supplier_code": "2952901000001101"
}See everything about lecanemab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.